Tenligress M 500 Tablet Sr 10

Tenligress M 500 Tablet Sr 10  is used in adults with type 2 diabetes to help control blood sugar levels when diet and exercise alone are not sufficient.

Uses of Tenligress M 500 Tablet Sr 10 are:

• Type 2 Diabetes: Improves insulin sensitivity and lowers blood glucose for better glycaemic control.
• After-Meal Blood Sugar Control: Helps prevent blood sugar spikes through its dual-action formula.

• Swallow the tablet whole with a glass of water during a meal.

• Do not split, crush, or chew the tablet; it must be swallowed whole.

• Never exceed the recommended dose without consulting your doctor.

• It's crucial not to stop taking this medicine without speaking to your doctor first.

Tenligress M 500 Tablet Sr 10 is taken orally.

Tenligress M 500 Tablet Sr 10 combines two active ingredients:

• Metformin (500 mg): As a biguanide antihyperglycemic agent, metformin enhances glucose tolerance in individuals with type 2 diabetes. It accomplishes this by reducing glucose production in the liver and decreasing glucose absorption in the intestines. Additionally, it helps increase peripheral glucose uptake and utilisation, thereby improving insulin sensitivity.

• Teneligliptin (20 mg): Classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor, teneligliptin works by slowing down the inactivation of incretin hormones. This process increases their concentrations in the bloodstream, leading to reduced fasting and postprandial glucose levels in a glucose-dependent manner among patients with type 2 diabetes.

• Store Tenligress M 500 Tablet Sr 10 in a dry place below 30°C.

• Shield it from light to maintain its effectiveness.

• Keep this medicine unreachable for children, ensuring their safety.

• Always check the expiration date before using the tablet.

• Incorporate a balanced diet rich in fibre and low in simple sugars to help manage your blood sugar levels.

• Regular physical activity like walking or yoga can also support glucose control, but always consult your doctor before starting any new exercise regimen.